Details werden geladen...
Trevogrumab Curbs Muscle Loss on GLP-1, Aids Regain After
The investigational antimyostatin drug improves restoration of lean mass after semaglutide discontinuation, with greater benefits observed in those with lower lean mass.
Ähnliche Seiten
Retatrutide Yields Significant Weight Loss in T2D
https://www.medscape.com/viewarticle/retatrutide-yields-significant-weight-loss-t2d-2026a10010n0Survodutide Lowers Weight and A1c in Adults With Obesity/T2D
https://www.medscape.com/viewarticle/drives-weight-loss-and-glycemic-control-adults-obesity-and-2026a10011e6EloraTZP Boosts Weight Loss, A1c Reduction in T2D
https://www.medscape.com/viewarticle/eloralintide-tirzepatide-combination-drives-greater-weight-2026a10010s0GIP/GLP-1 Ups Beta-Cell Function, Insulin Sensitivity in T2D
https://www.medscape.com/viewarticle/tirzepatide-ups-beta-cell-function-insulin-sensitivity-early-2026a10010fkType 1 Diabetes Overall, Type 2 Diabetes in Kids on the Rise
https://www.medscape.com/viewarticle/type-1-diabetes-overall-type-2-diabetes-kids-rise-2026a10010dq